Behavioral Health Business November 14, 2025
Behavioral health and addiction treatment providers are expecting renewed guidance from the Drug Enforcement Administration (DEA) around telehealth prescribing flexibilities for controlled substances, now that the longest government shutdown in the country’s history has been resolved.
A pending executive order sent to the Office of Management and Budget titled “Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” seems to suggest these provisions will be extended for another year. However, its exact details have yet to be released.
Previous telehealth prescribing extensions brought relief and ease to many providers who treat substance use disorders (SUDs), allowing them to more easily prescribe medications like methadone and buprenorphine for treatment without as many barriers.
These flexibilities increased patient...
Today's Sponsors
Today's Sponsor